Followers | 439 |
Posts | 41282 |
Boards Moderated | 0 |
Alias Born | 10/07/2010 |
Wednesday, January 18, 2023 9:18:04 AM
01/18/2023 Expert Market IconSMIT Schmitt Industries, Inc.
Pink Limited to Expert Market
Who was pumping while David Lazar was dumping???
https://www.otcmarkets.com/filing/html?id=16277096&guid=Cts-kqiHU8Fudth
Transaction in the Shares During the Past Sixty Days
Nature of Transaction Common Stock
Sold Price Per
Share($) Date of
Sale
DAVID E. LAZAR
Sale of Common Stock 159,900 0.32501 12/21/2022
Sale of Common Stock 51,000 0.27962 12/21/2022
Sale of Common Stock 148,259 0.25303 12/22/2022
1 Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $0.2900 to $0.3852, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
2 Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $0.2704 to $0.3089, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
3 Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $0.2162 to $0.3045, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
Recent SMIT News
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 09/08/2023 01:00:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM